FDA Approves Pradaxa® (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism Three pivotal trials showed PRADAXA as ...
Pradaxa (dabigatran etexilate) is prescribed to lower the risk of blood clots in specific situations. The drug comes as an oral capsule and oral pellets. It’s usually taken once or twice per day ...
Pradaxa (dabigatran etexilate) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it for the following uses in certain situations: Pradaxa may be taken on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback